{
  "id": "37becc0899343502",
  "title": "FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia",
  "description": "20251215T193000Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/fda-approves-lerodalcibep-for-hypercholesterolemia-and-heterozygous-familial-hypercholesterolemia",
  "published_at": "20251215T193000Z",
  "fetched_at": "2025-12-16T00:23:22.810654+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/fda-approves-lerodalcibep-for-hypercholesterolemia-and-heterozygous-familial-hypercholesterolemia",
    "url_mobile": "",
    "title": "FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia",
    "seendate": "20251215T193000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/aaa238369fcf47f64b3efbfa2060adea09b1d691-7200x4050.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}